Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,620 | 2 | 55.6% |
| Travel and Lodging | $2,043 | 6 | 24.6% |
| Food and Beverage | $1,641 | 86 | 19.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $6,845 | 15 | $0 (2018) |
| Allergan Inc. | $284.29 | 19 | $0 (2018) |
| Celgene Corporation | $220.11 | 10 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $188.11 | 9 | $0 (2018) |
| Biogen, Inc. | $129.79 | 10 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $126.22 | 6 | $0 (2019) |
| Lilly USA, LLC | $85.55 | 4 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $83.69 | 4 | $0 (2019) |
| Amgen Inc. | $69.50 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $66.02 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $129.79 | 10 | Biogen, Inc. ($129.79) |
| 2019 | $195.77 | 10 | Celgene Corporation ($40.67) |
| 2018 | $2,865 | 24 | Merck Sharp & Dohme Corporation ($2,459) |
| 2017 | $5,112 | 50 | Merck Sharp & Dohme Corporation ($4,386) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $2.14 | General |
| 10/21/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $17.96 | General |
| 09/23/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: NEUROLOGY | ||||||
| 09/09/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROLOGY | ||||||
| 09/09/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: NEUROLOGY | ||||||
| 08/12/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEUROLOGY | ||||||
| 08/05/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: NEUROLOGY | ||||||
| 07/22/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/25/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/25/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $15.75 | General |
| 04/11/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 04/10/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 03/28/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2019 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: XLH | ||||||
| 02/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/07/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CNS | ||||||
| 01/03/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $24.92 | General |
| 11/01/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 10/24/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: CNS | ||||||
| 10/18/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/14/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 27 | 29 | $4,817 | $517.25 |
| 2021 | 4 | 121 | 188 | $28,042 | $17,452 |
| 2020 | 3 | 102 | 146 | $18,727 | $10,494 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 29 | $4,817 | $517.25 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 126 | $20,665 | $13,260 | 64.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 24 | $5,348 | $3,062 | 57.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,423 | $838.53 | 58.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 25 | 25 | $606.36 | $292.12 | 48.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 111 | $15,343 | $8,301 | 54.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $2,966 | $1,990 | 67.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 19 | $417.96 | $202.56 | 48.5% |
About Dr. Martin Finkelstein, M.D
Dr. Martin Finkelstein, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033127998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Finkelstein, M.D has received a total of $8,304 in payments from pharmaceutical and medical device companies, with $129.79 received in 2021. These payments were reported across 94 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,620).
As a Medicare-enrolled provider, Finkelstein has provided services to 250 Medicare beneficiaries, totaling 363 services with total Medicare billing of $28,463. Data is available for 3 years (2020–2022), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 08/04/2006
- Last Updated 06/24/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033127998
Products in Payments
- ZOSTAVAX (Biological) $4,338
- PNEUMOVAX 23 (Biological) $2,459
- XARELTO (Drug) $188.11
- NUEDEXTA (Drug) $126.22
- ADUHELM (Biological) $109.69
- NAMZARIC (Drug) $97.94
- APTIOM (Drug) $83.69
- Prolia (Biological) $69.50
- FORTEO (Drug) $68.49
- TEFLARO (Drug) $61.65
- CHANTIX (Drug) $40.49
- FARXIGA (Drug) $36.81
- BELSOMRA (Drug) $32.92
- BYSTOLIC (Drug) $31.78
- LINZESS (Drug) $29.68
- ELIQUIS (Drug) $26.77
- VRAYLAR (Drug) $24.86
- MYRBETRIQ (Drug) $24.44
- COSENTYX (Biological) $24.23
- ENTRESTO (Drug) $24.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M